FR3104987B1 - Composition cosmétique comprenant de l’acide 2-glucoside ascorbique et de l’acide hyaluronique acétylé ou l’un de ses sels - Google Patents
Composition cosmétique comprenant de l’acide 2-glucoside ascorbique et de l’acide hyaluronique acétylé ou l’un de ses sels Download PDFInfo
- Publication number
- FR3104987B1 FR3104987B1 FR1914933A FR1914933A FR3104987B1 FR 3104987 B1 FR3104987 B1 FR 3104987B1 FR 1914933 A FR1914933 A FR 1914933A FR 1914933 A FR1914933 A FR 1914933A FR 3104987 B1 FR3104987 B1 FR 3104987B1
- Authority
- FR
- France
- Prior art keywords
- salts
- cosmetic composition
- acid
- acetylated hyaluronic
- ascorbic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 2
- 229960005070 ascorbic acid Drugs 0.000 title abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 2
- 239000011668 ascorbic acid Substances 0.000 title abstract 2
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 229920002674 hyaluronan Polymers 0.000 title abstract 2
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 159000000000 sodium salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne une composition cosmétique comprenant dans un milieu physiologiquement acceptable de l’acide 2-glucoside ascorbique et de l’acide hyaluronique acétylé ou un de ses sels, de préférence son sel de sodium.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1914933A FR3104987B1 (fr) | 2019-12-18 | 2019-12-18 | Composition cosmétique comprenant de l’acide 2-glucoside ascorbique et de l’acide hyaluronique acétylé ou l’un de ses sels |
PCT/FR2020/052490 WO2021123631A1 (fr) | 2019-12-18 | 2020-12-17 | Composition cosmétique comprenant de l'acide 2-glucoside ascorbique et de l'acide hyaluronique acétylé ou l'un de ses sels |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1914933A FR3104987B1 (fr) | 2019-12-18 | 2019-12-18 | Composition cosmétique comprenant de l’acide 2-glucoside ascorbique et de l’acide hyaluronique acétylé ou l’un de ses sels |
FR1914933 | 2019-12-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3104987A1 FR3104987A1 (fr) | 2021-06-25 |
FR3104987B1 true FR3104987B1 (fr) | 2023-06-30 |
Family
ID=69743565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1914933A Active FR3104987B1 (fr) | 2019-12-18 | 2019-12-18 | Composition cosmétique comprenant de l’acide 2-glucoside ascorbique et de l’acide hyaluronique acétylé ou l’un de ses sels |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3104987B1 (fr) |
WO (1) | WO2021123631A1 (fr) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070134265A1 (en) * | 2004-03-11 | 2007-06-14 | Shiseido Company, Ltd. | Anti-aging composition and collagen production promoting composition |
FR2924335B1 (fr) | 2007-11-30 | 2016-03-25 | Lvmh Rech | Utilisation de l'acide 2-glucoside ascorbique dans une composition cosmetique contre le vieillissement. |
EP2623092A4 (fr) * | 2010-10-01 | 2015-12-02 | Foret Co Ltd L | Composition cosmétique |
JP6071123B2 (ja) * | 2012-02-10 | 2017-02-01 | 株式会社 資生堂 | 水中油型乳化皮膚化粧料 |
WO2014103475A1 (fr) * | 2012-12-27 | 2014-07-03 | 株式会社林原 | Composition antivieillissement pour l'extérieur de la peau et son procédé de production |
GB201703850D0 (en) | 2017-03-10 | 2017-04-26 | Givaudan Sa | Improvements in or relating to organic compounds |
-
2019
- 2019-12-18 FR FR1914933A patent/FR3104987B1/fr active Active
-
2020
- 2020-12-17 WO PCT/FR2020/052490 patent/WO2021123631A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021123631A1 (fr) | 2021-06-24 |
FR3104987A1 (fr) | 2021-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015MU00865A (fr) | ||
UY33802A (es) | Composiciones inmunógenas que comprenden un antígeno relacionado con M72 y que tienen una fuerza iónica baja | |
EA201991532A1 (ru) | Применение хелатирующих агентов для улучшения стабильности цвета резорцинола | |
CO6290622A2 (es) | Composiciones de activo antitranspirante con un cromatograma sec que presenta una elevada intensidad de pico 4 sec para reducir la transpiración | |
EA201300830A1 (ru) | Полутвердый пищевой концентрат в виде пасты или геля | |
TR201907427T4 (tr) | Sulu ortamda, en az bi̇r hyalüroni̇k asi̇t ve suda çözünür en az bi̇r oktasülfat sükroz tuzu i̇çeren bi̇leşi̇m | |
EA202192392A1 (ru) | Способы получения биоконъюгатов полисахаридных о-антигенов e.coli, их композиции и способы их применения | |
MX2017007178A (es) | Formulaciones liquidas estables de virus de vacuna. | |
ZA202210899B (en) | Solutons for increasing the stability and shelf life of an organ and tissue preservation solution | |
MA38488A1 (fr) | Formes de sel de (s)-quinuclidin-3-yl (2-(2-(4-fluorophényl)thiazol-4-yl)propan-2-yl)carbamate | |
EA201190285A1 (ru) | Иммуногенные композиции, имеющие низкую концентрацию хлорида натрия | |
PH22012000673U1 (en) | Anhydrous antiperspirant compositions | |
AR092691A1 (es) | Composicion farmaceutica que comprende rebamipida | |
AU2017373587A1 (en) | Method for producing transparent preparations for examination by light microscopy | |
FR3104987B1 (fr) | Composition cosmétique comprenant de l’acide 2-glucoside ascorbique et de l’acide hyaluronique acétylé ou l’un de ses sels | |
EA201490127A1 (ru) | Офтальмологический раствор, содержащий гиалуроновую кислоту или ее соль и пропиленгликоль | |
EA201300675A1 (ru) | Антибактериальная микроэмульсионная композиция ополаскивателя для полости рта | |
FR2969924B1 (fr) | Composition comprenant un phosphate de tocopherol | |
EA201600381A1 (ru) | Соли 1-(3-метил-2-оксо-2,3-дигидро-1,3-бензоксазол-6-ил)-2,4-диоксо-3-[(1r)-4-(трифторометил)-2,3-дигидро-1h-инден-1-ил]-1,2,3,4-тетрагидропиримидин-5-карбоновой кислоты | |
NZ624275A (en) | Sustained-release preparation | |
FR3104436B1 (fr) | Composition cosmétique comprenant des extraits de grenadier et de pivoine | |
RU2010129784A (ru) | Способ приготовления противотуберкулезного лекарственного препарата | |
FR3104032B1 (fr) | Composition cosmétique comprenant des extraits de kigélia et de capucine | |
MX2021006606A (es) | Unguento oftalmologico hipertonico. | |
UA129572U (uk) | Добавка дієтична для застосування при онкологічних захворюваннях |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20210625 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |